RECELL GO mini
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
23. Dezember 2024 16:02 ET | AVITA Medical
AVITA Medical receives FDA approval for RECELL GO mini, optimizing treatment for smaller wounds and expanding patient accessibility.
Avita.png
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
19. Dezember 2024 17:05 ET | AVITA Medical
AVITA Medical announces FDA clearance for Cohealyx, a new collagen-based dermal matrix, expanding its addressable market.
Avita.png
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
18. Dezember 2024 16:08 ET | AVITA Medical
AVITA Medical to present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025, at 9:00 a.m. Pacific Time.
Avita.png
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25. November 2024 16:02 ET | AVITA Medical
VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care...
Avita.png
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
12. November 2024 16:03 ET | AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
Avita.png
AVITA Medical to Host Investor Webinar Briefing
08. November 2024 09:00 ET | AVITA Medical
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on November 12, 2024.
Avita.png
AVITA Medical Reports Third Quarter Financial Results
07. November 2024 16:03 ET | AVITA Medical
AVITA Medical reported third-quarter commercial revenue of $19.5 million, reflecting an approximately 44% increase over the same period last year.
Avita.png
AVITA Medical to Announce Third Quarter 2024 Financial Results
10. Oktober 2024 17:15 ET | AVITA Medical
AVITA Medical announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on November 7, 2024.
Avita.png
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
12. September 2024 16:05 ET | AVITA Medical
AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.
Avita.png
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
10. September 2024 16:03 ET | AVITA Medical
AVITA Medical will participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG8) Conference in New York on September 12, 2024.